EUVIMEDAtrasti EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury: Study Protocol for a Pilot Randomized Controlled Trial

Yu Deng iD, Guoyi Gao iD, Liang Wu iD

JMIR Research Protocols · 2026-08-14 · 15 · e95327-e95327

DOI: 10.2196/95327 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-08-14. Written by Yu Deng and 2 co-authors. Institution: Department of Neurosurgery, Beijing Tiantan Hospital, No. 119, South Fourth Ring West Road, Fengtai District, Beijing, China, Beijing, 100070, China,…. Major MEDLINE topics: Brain Injuries, Traumatic, Median Nerve, Cognitive Dysfunction, Electric Stimulation Therapy. 29 references. The full text is freely available in PubMed Central.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Currently, the treatment of cognitive dysfunction after acute traumatic brain injury (TBI) remains a challenge, and novel therapeutic methods are urgently needed. Median nerve stimulation (MNS) is a noninvasive neuromodulation technique that has recently shown positive effects in promoting recovery from coma after acute brain injury. It has been shown to improve cognition in healthy volunteers, and may be a potential therapeutic approach for cognitive dysfunction in patients with acute TBI.

Objective

The primary aim of this study is to evaluate the feasibility, safety, and preliminary efficacy of MNS for cognitive dysfunction in patients with acute TBI.

Methods

This study is designed as a prospective, single-center, assessor-blinded, sham-controlled, randomized pilot study. Thirty adult patients with cognitive dysfunction after TBI will be enrolled and randomized to either the stimulation or sham group in a 1:1 allocation ratio. In the stimulation group, MNS is performed on the right wrist (40 Hz, pulse width 300 µs, 20 s on/40 s off, 8 hours per day). The sham group will receive stimulation using an identical device set to deliver 0 mA. Feasibility, safety, and preliminary efficacy will be evaluated at 1 and 3 months after the injury. Feasibility and acceptability will be assessed via recruitment, adherence, retention, and participant-reported acceptability using Likert scales. These measures will be summarized descriptively, and completion rates will be calculated and reported. Safety will be primarily assessed by ascertainment of adverse events from enrollment to 3 months. Further safety assessment will examine side effects using a Likert questionnaire and the impact on peripheral hemodynamic responses. Additionally, the potential efficacy of MNS on cognitive dysfunction will be assessed using multiple cognitive scales; neuroradiological tests, including magnetic resonance imaging and magnetoencephalography; and cognitive-related serum biomarkers.

Results

Ethics approval was obtained in January 2025, and the trial was registered on ClinicalTrials.gov in February 2026. Participant recruitment is scheduled to begin in July 2026, with completion anticipated in June 2027. Data analysis will commence after completion of follow-up assessments, and study findings are expected to be published in late 2027.

Conclusions

This pilot trial will provide preliminary evidence on the feasibility and safety of MNS as a novel intervention for cognitive dysfunction after acute TBI. The results will guide the development of larger-scale trials and optimization of study design.

Subjects

MeSH terms (MEDLINE)

Brain Injuries, TraumaticMedian NerveCognitive DysfunctionElectric Stimulation TherapyHumansPilot ProjectsFeasibility StudiesAdultProspective StudiesMaleRandomized Controlled Trials as TopicFemaleMiddle AgedYoung AdultTreatment Outcome

Author keywords

cognitive dysfunctionmedian nerve stimulationneuromodulationpilot randomized controlled trialtraumatic brain injury

Authors and institutions

  • Department of Neurosurgery, Beijing Tiantan Hospital, No. 119, South Fourth Ring West Road, Fengtai District, Beijing, China, Beijing, 100070, China, 1 18301674233.

ORCID profiles: Yu Deng, Guoyi Gao, Liang Wu

Cite

APA

Deng, Y., Gao, G., & Wu, L. (2026). Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury: Study Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols, 15, e95327-e95327. https://doi.org/10.2196/95327

Vancouver

Deng Y, Gao G, Wu L. Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury: Study Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e95327-e95327. doi:10.2196/95327

BibTeX
@article{Deng2026,
  author = {Deng, Yu and Gao, Guoyi and Wu, Liang},
  title = {Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury: Study Protocol for a Pilot Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e95327--e95327},
  doi = {10.2196/95327}
}
Start for free →